Ellagic acid and pentagalloylglucose are potential inhibitors of prion protein fibrillization.
Int J Biol Macromol. 2021 Mar 1 ;172:371-380. Epub 2021 Jan 15. PMID: 33460657
Prion diseases are fatal neurodegenerative diseases caused by the conformational transition of the cellular prion protein (PrP) to the abnormal pathological prion protein (PrP). In this work, the effects of ellagic acid (EA) and pentagalloylglucose (PGG) on prion protein (PrP) fibrillization were investigated. Fluorescence quenching experiments indicated that both EA and PGG could specifically interact with native human PrP with binding affinities of 1.92 × 10and 2.36 × 10 L·mol, respectively. Thioflavin-T (ThT) fluorescence assays showed that the binding of EA or PPG could effectively inhibit the nucleation and elongation of PrP fibrilization and reduce the amount of PrP fibrils generated. EA and PGG could also lead to a significant disaggregation of PrP fibrils. Circular dichroism (CD) measurements suggested that EA- or PPG-bound PrP could preserve a higher content ofα-helical structures than β-sheet-rich PrP fibrils. The PrP aggregates formed in the presence of EA or PGG showed lower resistance to proteinase K (PK) digestion. Overall, the present work reported the inhibitory effect of EA and PGG on PrP fibrillization. These two natural polyphenols could be potential prodrug molecules for the prevention and treatment of prion diseases.